Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study

Serum Dehydroepiandrosterone Sulfate and Risk for Type 2 Diabetes in Older Men and Women: The Pro.V.A Study

(2016) Nicola Veronese et al.   Canadian Journal of Diabetes

Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans

(2016) Edward P. Weiss et al.   Aging-US

The Rotterdam Study: 2016 objectives and design update

(2015) Albert Hofman et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Adrenal Androgen Excess and Body Mass Index in Polycystic Ovary Syndrome

(2015) Carlos Moran et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Steroid Sex Hormones, Sex Hormone–Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program

(2015) K. J. Mather et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione

(2014) Michael W. O'Reilly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study

(2012) Maarten J. G. Leening et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

2011 Compendium of Physical Activities

(2011) BARBARA E. AINSWORTH et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE

The Association of Endogenous Sex Hormones, Adiposity, and Insulin Resistance with Incident Diabetes in Postmenopausal Women

(2009) Rita Rastogi Kalyani et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?

(2008) B. Haibe-Kains et al.   BIOINFORMATICS